Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bingkun Li

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Pharmacology|October 13, 2022
Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosisZhiwen Jiang, Yinyi Wei, Weie Huang, et al.
Journal of Robotic Surgery|January 21, 2026
Safety and efficacy of the Chinese surgical robotic system (EDGE MP1000 & MP2000) for robot-assisted radical prostatectomy: results from a single high-volume centerYiming Zhang, Peng Xu, Yong Wen, et al.
Mycopathologia|February 5, 2025
Voriconazole Steady-State Trough Concentrations and Clinical Outcomes in Patients with TalaromycosisZhiwen Jiang, Cong Song, Bingkun Li, et al.
Chemical Society Reviews|December 4, 2024
Advanced systems for enhanced CO<sub>2</sub> electroreductionWenfu Xie, Bingkun Li, Lu Liu, et al.
Acta Pharmaceutica Sinica. B|March 8, 2022
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy <i>via</i> diminishing PD-L1 and promoting CD8<sup>+</sup> T cell-mediated ferroptosis in castration-resistant prostate cancerXumin Zhou, Libin Zou, Hangyu Liao, et al.
European Child & Adolescent Psychiatry|October 15, 2025
Dual deficits in auditory selective attention in children with attention deficit hyperactivity disorder: insights from multivariate pattern analysis of EEGYiyang Wang, Han Yang, Weizhen Yin, et al.
European Journal of Medicinal Chemistry|October 18, 2023
Discovery of highly potent and selective KRAS<sup>G12C</sup> degraders by VHL-recruiting PROTACs for the treatment of tumors with KRAS<sup>G12C</sup>-MutationNing Yang, Zhiya Fan, Shiyang Sun, et al.
Oncology Research|October 6, 2025
Discovery and Characterization of Novel IKZF1/3 Glue Degraders against Multiple Hematological Cancer Cell LinesTing Wei, Pengli Wei, Yalei Wang, et al.
Journal of Medicinal Chemistry|July 16, 2025
Novel Highly Potent c-Met Degraders against a Broad Range of CancersChangkai Jia, Pengli Wei, Shiyang Sun, et al.
Journal of Medicinal Chemistry|August 1, 2025
Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological CancersTing Wei, Shiyang Sun, Xiaotong Hu, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Pharmacology|October 13, 2022
Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosisZhiwen Jiang, Yinyi Wei, Weie Huang, et al.
Journal of Robotic Surgery|January 21, 2026
Safety and efficacy of the Chinese surgical robotic system (EDGE MP1000 & MP2000) for robot-assisted radical prostatectomy: results from a single high-volume centerYiming Zhang, Peng Xu, Yong Wen, et al.
Mycopathologia|February 5, 2025
Voriconazole Steady-State Trough Concentrations and Clinical Outcomes in Patients with TalaromycosisZhiwen Jiang, Cong Song, Bingkun Li, et al.
Chemical Society Reviews|December 4, 2024
Advanced systems for enhanced CO<sub>2</sub> electroreductionWenfu Xie, Bingkun Li, Lu Liu, et al.
Acta Pharmaceutica Sinica. B|March 8, 2022
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy <i>via</i> diminishing PD-L1 and promoting CD8<sup>+</sup> T cell-mediated ferroptosis in castration-resistant prostate cancerXumin Zhou, Libin Zou, Hangyu Liao, et al.
European Child & Adolescent Psychiatry|October 15, 2025
Dual deficits in auditory selective attention in children with attention deficit hyperactivity disorder: insights from multivariate pattern analysis of EEGYiyang Wang, Han Yang, Weizhen Yin, et al.
European Journal of Medicinal Chemistry|October 18, 2023
Discovery of highly potent and selective KRAS<sup>G12C</sup> degraders by VHL-recruiting PROTACs for the treatment of tumors with KRAS<sup>G12C</sup>-MutationNing Yang, Zhiya Fan, Shiyang Sun, et al.
Oncology Research|October 6, 2025
Discovery and Characterization of Novel IKZF1/3 Glue Degraders against Multiple Hematological Cancer Cell LinesTing Wei, Pengli Wei, Yalei Wang, et al.
Journal of Medicinal Chemistry|July 16, 2025
Novel Highly Potent c-Met Degraders against a Broad Range of CancersChangkai Jia, Pengli Wei, Shiyang Sun, et al.
Journal of Medicinal Chemistry|August 1, 2025
Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological CancersTing Wei, Shiyang Sun, Xiaotong Hu, et al.
Pageof 8